5G health concerns have generated more public attention — and more noise — than almost any technology topic in recent years. The debate is polarized between those who dismiss all concerns as conspiracy theory and those who attribute sweeping health effects to 5G without adequate evidence. Neither position is scientifically honest. The actual research picture is more nuanced and more worth understanding.
What 5G Actually Is: Two Different Technologies
Understanding 5G health claims requires understanding that "5G" describes two meaningfully different technology deployments that happen to share a name.
Sub-6 GHz 5G operates in the same frequency ranges as existing 4G LTE, Wi-Fi 6, and Bluetooth — roughly 600 MHz to 6 GHz. The frequencies are not new; the infrastructure is more dense, the protocols are updated, and data throughput is higher. The biological research on these frequencies is extensive — decades of work on mobile phone radiation, Wi-Fi exposure, and RF EMF generally applies directly to sub-6 GHz 5G.
5G Millimeter Wave (mmWave) operates at 24–100 GHz — frequencies not previously used in consumer devices at scale. These signals have shorter wavelengths, cannot penetrate building materials (which is why mmWave requires dense small-cell infrastructure in urban areas), and interact primarily with skin and eye surfaces rather than deeper tissues. This is the genuinely new territory for consumer-scale health research.
The Research on Sub-6 GHz Frequencies
The biological research on the frequency ranges used by sub-6 GHz 5G is substantial. The Pavlov Institute EEG program, the Havas cardiovascular research, the IFRAN cytogenetics program, the National Toxicology Program animal studies — all of this research examined effects at frequencies directly overlapping with sub-6 GHz 5G.
The findings from this body of research are consistent: wireless EMF at consumer device frequencies and intensities produces measurable biological effects in EEG parameters, heart rate variability, chromosome aberration rates, and DNA strand break markers. These are non-thermal effects — they occur below the thermal threshold captured by SAR measurements and current regulatory limits.
This matters for the 5G debate: the scientific basis for concern about non-thermal RF biological effects is not a 5G-specific hypothesis invented after 5G deployment. It is a research finding that predates 5G by decades, across frequencies that 5G sub-6 GHz shares with its predecessors.
"The scientific basis for concern about non-thermal RF biological effects is not a 5G-specific hypothesis invented after 5G deployment. It is a research finding that predates 5G by decades, across frequencies that sub-6 GHz 5G shares with its predecessors."
The Research on 5G Millimeter Wave
Millimeter wave frequencies are genuinely less studied at consumer scale than sub-6 GHz. What is known:
Tissue penetration depth. mmWave penetrates roughly 1–2 mm into tissue — primarily skin and the corneal layer of the eye. This is shallower than lower-frequency RF, which penetrates several centimeters. Shallow penetration doesn't mean no biological effect; skin contains nerve endings, immune cells, and structures that respond to surface-level electromagnetic fields.
Thermal effects at higher intensities. mmWave is used in airport security body scanners and has been studied in the context of crowd-control directed-energy systems — both applications involve intensities far above consumer device levels. At consumer mmWave intensities, thermal effects are not the primary concern.
The 2026 thermal imaging research. Thermal imaging studies published in 2026 documented measurable field-matter interaction at 6 GHz and above — in the frequency range of Wi-Fi 6 and early 5G mmWave deployments — using Aires fractal coherent transformers. This is consistent with the VGTU physics testing that documented field modification at 5G-relevant frequencies.
The US patent coverage. The Aires Lifetune fractal coherent transformer is covered by US patent US12239835B2, which explicitly covers the mechanism across frequencies from 2.4 GHz through 28 GHz — the full range of current consumer and enterprise 5G deployments. The patent examiner had access to the full research foundation and granted the patent after examining prior art across this frequency range.
What the 2022 Springer Model Shows
A peer-reviewed computational paper published in Springer in 2022 (Lukyanov, Kopyltsov, and Serov) modeled the Aires Lifetune resonator's electromagnetic response to 6 GHz input — precisely the frequency of Wi-Fi 6 and early 5G deployments. The model confirmed the fractal diffraction mechanism: the resonator redistributes the field spatially, producing measurable coherence modification. The model matched the physical bench measurements from VGTU testing. Two independent methodologies — physical measurement and computational simulation — converging on the same result at 5G-relevant frequencies.
"Two independent methodologies — physical measurement and computational simulation — converging on the same result at 5G-relevant frequencies."
The Regulatory Picture and Its Limitations
Current FCC exposure limits for 5G are based on thermal effects — the SAR framework and its mmWave equivalent (power density limits). Regulatory agencies have not established non-thermal exposure limits, because the non-thermal research is not yet at the stage where a dose-response relationship has been characterized precisely enough to set a regulatory threshold.
The absence of non-thermal regulatory limits does not mean non-thermal effects have been ruled out. It means the regulatory framework has not yet caught up with the research. This is a known gap in the literature — the WHO, IARC, and the research community all acknowledge that non-thermal effects are an active research area and that the regulatory framework addresses only the thermal dimension.
"The absence of non-thermal regulatory limits does not mean non-thermal effects have been ruled out. It means the regulatory framework has not yet caught up with the research."
What You Can Reasonably Conclude
The honest summary of the 5G health evidence is this:
The sub-6 GHz frequencies used by most 5G infrastructure are not new — they share ranges with 4G LTE, Wi-Fi, and Bluetooth. The biological research on these frequencies provides a substantial evidence base for non-thermal effects that is not specific to 5G. These findings are real and should not be dismissed.
The mmWave frequencies that define 5G's high-bandwidth capability are newer at consumer scale. The research is less developed, the tissue penetration is shallower, and the specific biological effects at consumer intensities are an active area. Certainty is not warranted in either direction.
The structural field modulation approach — fractal diffraction that modifies field coherence properties across a broad frequency range — is specifically designed and patented to address the full consumer wireless spectrum including 5G. The mechanism has been independently verified at 5G-relevant frequencies.
For the full research foundation including the VGTU testing and Springer model, see research overview. For the 5G millimeter wave article specifically, see 5G Millimeter Wave: What the Evidence Shows. For the clinical biological research, see clinical research summary.